Anna England

Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial

Xinxue Liu, R. H. Shaw, Arabella Stuart et al. · The Lancet · 2021 · 539 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +7

Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial

Arabella Stuart, R. H. Shaw, Xinxue Liu et al. · The Lancet · 2021 · 218 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +8

Antibody Responses After Primary Immunization in Infants Born to Women Receiving a Pertussis-containing Vaccine During Pregnancy: Single Arm Observational Study With a Historical Comparator

Shamez Ladhani, Nick Andrews, Jo Southern et al. · Clinical Infectious Diseases · 2015 · 173 citations · Full text

Kinetics of Antibody Persistence following Administration of a Combination Meningococcal Serogroup C and <i>Haemophilus influenzae</i> Type b Conjugate Vaccine in Healthy Infants in the United Kingdom Primed with a Monovalent Meningococcal Serogroup C Vaccine

Ray Borrow, Nick Andrews, Helen Findlow et al. · Clinical and Vaccine Immunology · 2009 · 113 citations · Full text

Vaccination, Vaccinology, Vaccine Development +14

Randomized Trial to Compare the Immunogenicity and Safety of a CRM or TT Conjugated Quadrivalent Meningococcal Vaccine in Teenagers who Received a CRM or TT Conjugated Serogroup C Vaccine at Preschool Age

David Ishola, Nick Andrews, Pauline Waight et al. · The Pediatric Infectious Disease Journal · 2015 · 33 citations